Latest Regulatory Approval News

Neurotech International has opened the first clinical site for its pivotal Phase 3 trial of NTI164, targeting core symptoms of Autism Spectrum Disorder in children. This milestone marks a key step toward potential regulatory approval and commercialisation.

Triangle Energy is set to spin out its Philippine oil and gas assets into a new ASX-listed company, Tetragon Energy, offering shareholders direct exposure to promising Asian resources.

European Resources Limited (ASX: ERE) has announced a $4.26 million renounceable entitlement offer to accelerate exploration and metallurgical work at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, providing shareholders with a strategic opportunity amid significant recent resource growth.

Rox Resources has approved the Final Investment Decision for its Youanmi Gold Project, fully funded and ready to begin construction targeting first gold pour by mid-2027.

New Frontier Minerals has secured technical approval for its Mining Lease Application at the Big One Copper Deposit, setting the stage for potential near-term copper production amid a tightening global copper market.

Kina Securities Limited has launched its inaugural unsecured subordinated bond issue worth PGK 235 million, offering a fixed 7.55% coupon over 10 years, marking a significant step in Papua New Guinea's capital markets.

Latitude Group Holdings is considering launching a new Capital Notes 2 offer, potentially allowing existing CN1 holders to reinvest. The offer will require applications through appointed Syndicate Brokers under updated regulatory rules.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.

Perpetual Limited has agreed to sell its Wealth Management business to Bain Capital for an upfront $500 million, marking a strategic shift towards asset management and corporate trustee services.

Dimerix Limited is set to conduct a blinded statistical review of its pivotal Phase 3 ACTION3 study in March 2026, aiming to confirm the trial remains powered to demonstrate the primary endpoint of proteinuria reduction in FSGS patients.

Syrah Resources has secured an extension to the cure date for an alleged default under its Tesla offtake agreement, pushing the deadline from March to June 2026 as both parties work to resolve outstanding issues.

West Cobar Metals has significantly expanded its exploration tenure in NSW’s Cobar district by applying for two new licences, increasing its coverage to around 1,090 km² and unlocking fresh potential for copper, gold, antimony, and silver discoveries.